Clinical Trials Directory

Trials / Completed

CompletedNCT05822518

Outcome of Perioperative Immune Enhancing Nutrition in Patients Undergoing Radical Cystectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
Menoufia University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the outcome of perioperative immune-nutrition with glutamine, arginine and fish oil in patients undergoing radical cystectomy as regards to enhancement of healing, increasing immunity and improving overall health status.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTNeo-mune powder (otsuka pharmaceutical)* Preoperative: Neo-mune (otsuka pharmaceutical) powder 60 gm o.d. orally (contains glutamine, arginine and fish oil) for 3 days. * Postoperative: Neo-mune (otsuka pharmaceutical) powder 60 gm o.d. orally (contains glutamine, arginine and fish oil) for 2 weeks starting when the intestinal sounds are audible.
DRUGDipeptiven solution (Fresenius Kabi pharmaceutical)Dipeptiven (Fresenius Kabi pharmaceutical) solution 50 mg o.d IV ( contains L-ananyl-L-glutamine dipeptide) post operatively for 5 days starting from the operation day.

Timeline

Start date
2022-06-01
Primary completion
2023-11-30
Completion
2024-02-01
First posted
2023-04-20
Last updated
2024-03-26

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05822518. Inclusion in this directory is not an endorsement.